Human chorionic gonadotropin (hCG) is a glycoprotein hormone produced in pregnancy by the developing embryo after conception and later by the syncytiotrophoblast to prevent disintegration of the corpus luteum of the ovary. hCG also plays a role in cellular differentiation/proliferation and may activate apoptosis (1). hCG is extensively used as a parenteral fertility medication in lieu of luteinizing hormone.
The wild-type rats (NMRI) were purchased from the Pasteur Institute of Iran, Karaj, all weighing 180-200 g and were acclimatized at proper rodent diet and 12h/12h day/night cycle.
Percentage of the injected dose in tissue (ID g -1 , %) was determined using a high purity germanium (HPGe) detector coupled with a Canberra TM (model GC1020-7500SL, USA) multichannel analyzer based on the area under the curve for 184 keV photopeak and the calculated counting system efficiency.
Procedures
Production of 67 Zn(p,2n) 67 Ga was used as the best nuclear reaction for the production of 67 Ga. Impurities could be removed in the radiochemical separation process. After the target bombardment process, chemical separation was carried out in the no--carrier-added form. The irradiated target was dissolved in 10 mol L -1 HCl (15 mL) and the solution was passed through a cation-exchange resin (AG 50W, H + form 37-74 mm), which had been pre-conditioned by passing 9 mol L -1 HCl. The column was then washed with 25 mL of 9 mol L -1 HCl at a rate of 1 mL min -1 to remove copper and zinc ions. To the eluent, 30 mL water plus about 100 mL of 6 mol L -1 HCl solution was added. The latter solution was loaded on another exchange resin (AG1X8 Cl -form, 74-149 mm) pretreated with 6 mol L -1 HCl (100 mL). Finally, gallium-67 was eluted as [ 67 Ga]GaCl 3 using 2 mol L -1 HCl (50 mL); the whole process took about 60 min.
Radionuclide purity control. -Gamma spectroscopy of the final sample was carried out by counting in a high purity germanium detector coupled to a Canberra TM multi--channel analyzer for 1000 seconds.
Chemical purity control. -The presence of zinc and copper cations was checked by polarography. The area under the curve of the polarogram of test samples was lower than that of the standards even at 1 mg mL -1 of standard zinc and copper.
Conjugation of ccDTPA with human recombinant hCG. -The chelator ccDTPA was conjugated to the hCG using slightly modified cyclic anhydride method (16) . Conjugation was performed at a 1:1 molar ratio. In brief, 20 mL of a 1 mg mL -1 suspension of ccDTPA in dry chloroform (Merck, Germany) was pipetted under ultrasonication and transferred to a glass tube. The chloroform was evaporated under a gentle stream of nitrogen. Commercially available hCG (1500 IU, 1 mL, pH 8, » 3 nmol) (17) was subsequently added and gently mixed at room temperature for 60 min. 67 Ga. -The hCG conjugate was labeled using an optimized protocol according to the literature (18) . Typically, 74 MBq of 67 Ga-chloride (in 0.2 mol L -1 HCl) was added to a conical vial and dried under a nitrogen flow. To the 67 Ga containing vial, the conjugated fraction was added in 1 mL of phosphate buffer (0.1 mol L -1 , pH 8) and mixed gently for 30 seconds. The resulting solution was incubated at room temperature for 30 minutes. Following incubation, the radiolabeled hCG conjugate was checked using PC methods for purity. In case of the presence of unreacted amounts of impurities, the sample can be purified by solid phase extraction using C 18 Sep-Pak. Briefly, the column was pretreated with absolute ethanol and water, respectively, followed by injection of the radiolabeling mixture. The column was left at room tempera-ture for 5 min and was then washed with water fractions until the flow-through activity in each fraction was less than 10 mCi. Finally, the radiolabeled compound was eluted from the column using 1 mL-fractions of citrate buffer (pH 5.5). Control labeling experiments were also performed using 67 GaCl 3 , and ccDTPA with 67 GaCl 3 . High performance liquid chromatography. -HPLC was performed on the final preparation using reverse stationary phase. Acetate buffer solution (50 mmol L -1 pH 5.5) was eluent A and citrate buffer solution was B (50 mmol L -1 , pH 4) (flow rate 1 mL min -1 ) for 20 min in order to elute low molecular mass components. Radiolabeled peptide was eluted using the following gradients: 100 % A, 0 % B 5 min, 70 % A, 30 % B 5 min, 50 % A, 50 % B 5 min, 0 % A, 100 % B 5 min.
Radiolabeling of hCG conjugate with

Quality control of [
Stability testing of the radiolabeled compound. -Stability of 67 Ga-DTPA-hCG in the phosphate buffer solution was determined by storing the final solution at 4°C for 4 hours and performing frequent PC analyses to determine radiochemical purity. PC analysis of the conjugated product was also performed to monitor degradation products or other impurities after the conjugated DTPA-hCG was stored at -20°C for more than 1 month. After subsequent 67 Ga-labelling of the stored conjugated product, both the labeling efficiency and radiochemical purity were determined.
Stability testing of the radiolabeled compound in the presence of serum. -Labeled compound stability in serum was assessed by gel filtration on a Sepharose column. The column was equilibrated with PBS and eluted with PBS at a flow rate of 0.5 mL min -1 at room temperature; 0.5 mL fractions were collected. 67 Ga-DTPA-hCG in wild-type rats. -To determine its biodistribution, 67 Ga-DTPA-hCG was administered to wild-type rats. A volume (50 mL) of final 67 Ga--DTPA-hCG solution containing 40 ± 2 mCi radioactivity was injected intravenously to rats through tail veins. The animals were sacrificed at exact time intervals (0.25, 0.5, 1, 2, 3 and 24 h). The specific activity of different organs was calculated as percentage of the area under the curve of 184 keV peak per gram using an HPGe detector.
Biodistribution of
RESULTS AND DISCUSSION
The labeling yield of 67 Ga-DTPA-hCG has been studied in a wide range of hCG/ DTPA ratios in order to optimize the process and to improve 67 Ga-DTPA-hCG performance in vitro. The overall radiolabeling efficiency was over 80 %. Because of its isoelectric point (IEP) of around 4, hCG is soluble in physiological serum pH (5.5-7) being adequately stable (19) . However, its structural integrity is strongly dependent on the disulphide bonds, and its reduction completely destroys the structure; thus, the radiolabeling strategies based on redox reactions cannot be employed.
Regarding the peptide sequence for hCG for alpha and beta subunits, the existence of 6 lysine moieties in the alpha subunit and 4 in the beta subunit, can load to NH 2 -mediated conjugation through ccDTPA acylation.
The eluted fractions were checked for the presence of radioactivity in order to determine the 67 Ga-DTPA-hCG containing fractions. The fraction with maximum radioactivity was chosen as the suitable final product for quality control and that with appropriate specific activity for animal tests. The radiolabeling reached 95 % after 60 min.
For better radiochemical purity, solid-phase extraction using a C 18 column was used. The radiolabeled mixture was loaded on the pre-conditioned Sep-Pak Columm. Eluting the loaded column with water removed free 67 Ga 3+ as well as 67 Ga-DTPA due to their ionic properties. After purging the column with nitrogen for 5 minutes, the radiolabeled protein was eluted using citrate buffer in the first 3 elutions. At this stage, the buffer eluted fraction with the highest activity was tested by HPLC in order to determine its radiochemical purity before administration to wild-type rats for biodistribution studies. Fig. 1a shows the HPLC chromatogram of 67 Ga 3+ . The fast eluting component (2.79 min) was shown to be a mixture of free 67 Ga and 67 Ga-DTPA which was washed out on the reverse phase stationary phase. The radiolabeled protein was washed out in 14.78 minutes (Fig. 1b) .
It has been already shown that the median in vivo and in vitro biopotency for hCG is approximately 13000 IU mg -1 , with a range from 8360 to 16800 IU mg -1 (22) . Thus, considering the used (74 MBq) and the radiochemical purity of the final purified sample (95 %), a specific activity of 22-23 TBq mmol -1 was obtained after Sep-Pak purification.
Stability of the radiolabeled protein in vitro was determined after challenge with phosphate-buffered saline and serum. PC analysis showed that the proteins retained the radiolabel over a period of 1 hour in final solution.
These results were confirmed by gel filtration chromatography. After incubation of and there was no evidence of any large-scale release of free Ga resulting in the appearance of a new radiopeak. Similarly, gel filtration chromatography of [ 67 Ga]-DTPA-hCG after a 2-h incubation with human serum showed that the radioactivity still eluted in the same fraction. Thus, there was no evidence of either degradation or transchelation of 67 Ga to other serum proteins over a time period.
The distribution of free 67 GaCl 3 in appropriate buffer has been already reported elsewhere (21) Fig. 2 demonstrates the biodistribution of [ 67 Ga]-DTPA-hCG among tissues in male wild-type rats. A volume (0.1 mL) of final [ 67 Ga]-DTPA-hCG solution containing 40 mCi of radioactivity was injected into the dorsal tail vein. The total amount of radioactivity injected into each rat was determined by measuring the 1-mL syringe before and after injection in a dose calibrator with fixed geometry.
The animals were sacrificed by ether asyxphycation at selected times after injection (0.25 h to 2 h), the tissues (blood, heart, spleen, kidneys, liver, intestine, muscle, bone, brain, stomach, lung, skin, pancreas, bladder and testes) were weighed and their specific activities were determined with a g-ray scintillation detector as percent of the area under the curve of 184 keV per gram of tissue.
The radiolabeled hormone is gradually removed from the circulation and possible serum protein binding exists for this hormone. Most non-glycosylated proteins mainly possess hepatic accumulation, while due to the existence of residual sugar moieties on the hCG structure (leading to more solubility) liver uptake is not significant in this case.
Skin, muscle, brain pancreas and also kidney demonstrated low uptake; however, spleen demonstrated high uptake. Up to 120 minutes the testes showed low uptake while after 240 minutes 16 % of the tracer accumulated in the testes.
hCG transport in rat testicular microvasculature has been already studied by electron microscopy and by analyzing the transfer of the radiolabeled hormone. It has been observed that the same receptor molecule which is present in target Leydig cells is also involved in transcytosis through the endothelial cells (22) . The hormone can be internalized by coated pits and vesicles on the luminal side of the endothelium. It was then localized in the endosomal compartment and subsequently appeared to be delivered by smooth vesicles into the subendothelial space.
hCG receptors are widely expressed in gonadal cells; however, the presence of these receptors was also detected in several other non-gonadal female and male tissues. The expression level of non-gonadal hCG receptors is much lower than in the gonads, although their expression is regulated by similar mechanisms and observed in malignancies (20) .
For better comparison, the target/blood and target/muscle ratios were determined from ID g -1 (%) curves to demonstrate the time dependence of specific uptake in the target organ. The significance of uptake in gonadal tissue was observed at least 3 hours after administration of the tracer in both cases. However, the hCG hormone partly remained in serum binding species while after 24 hours major accumulation with the lowest background was in the testes (Fig. 3) .
CONCLUSIONS
Total labeling and formulation of [ 67 Ga]-DTPA-HCG took about 60 minutes. A suitable specific activity product was formed via insertion of 67 Ga cation. No other labeled conjugates were observed upon PC and/or HPLC analysis of the final preparations. The radio-labeled complex was stable in human serum for at least 2 hours and no significant amount of free 67 Ga or 67 Ga-DTPA was observed. A 95 % radiochemical purity was detected by HPLC. The final preparation was administered to wild-type rats and biodistribution of the radiopharmaceutical was checked 0.25 to 24 hours later. In 2-3 hours, the radiolabeled hormone was cleared from the blood circle and most of the tracer accumulated in spleen. After 3-24 h, major tracer uptake was observed in the testes. Target/ muscle ratio after 24 h reached 40, demonstrating specific accumulation on the hCGR positive tissues. [ 67 Ga]-DTPA-hCG can be a suitable probe for biodistribution of hCGR in various physiological and malignant diseases with over-expressed hCGRs.
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